معرفی
Robert C. Rizzo is a Professor in the Department of Pharmacological Sciences at Stony Brook University, specializing in Computational Structural Biology. With an extensive publication record spanning over two decades and significant citation metrics (6979 total citations, h-index of 36), his research has made substantial contributions to the field of computational drug discovery.
Dr. Rizzo's research interests center on computational methods for drug discovery, particularly the development and application of the DOCK software platform for molecular docking and structure-based drug design. His work spans multiple therapeutic areas including cancer (particularly prostate cancer), viral infections (HIV, Ebola, Zika, SARS-CoV-2), and other conditions where computational approaches can identify novel therapeutic targets and compounds. His expertise encompasses protein-ligand interactions, virtual screening, de novo drug design, and the development of algorithms for molecular modeling.
Analysis of his recent publications reveals a strong focus on advancing computational methodologies for drug discovery, with particular emphasis on the DOCK software platform. His work demonstrates consistent innovation in molecular docking algorithms, scoring functions, and structure-based design approaches applied to diverse biological targets. The research shows a progression from fundamental method development to application against specific disease targets, particularly in oncology and infectious diseases.
Dr. Rizzo has received significant recognition in his field as evidenced by his substantial citation record, though specific awards are not detailed in the available information. His work has contributed to advancing computational approaches in drug discovery, with applications across multiple therapeutic areas.
His research program involves substantial computational work, likely supported by grants from major funding agencies in computational biology and drug discovery. While specific grant information isn't provided, the scope and continuity of his publication record suggest sustained research funding.
